Drug Shortage Report for CLINDAMYCIN INJECTION IN 5% DEXTROSE
Report ID | 183714 |
Drug Identification Number | 02485478 |
Brand name | CLINDAMYCIN INJECTION IN 5% DEXTROSE |
Common or Proper name | CLINDAMYCIN INJECTION IN 5% DEXTROSE |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 600MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 50mL |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2023-06-10 |
Actual start date | 2023-06-10 |
Estimated end date | 2023-10-31 |
Actual end date | 2023-10-31 |
Shortage status | Resolved |
Updated date | 2023-11-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-11-01 | English | Compare |
v7 | 2023-10-31 | French | Compare |
v6 | 2023-10-31 | English | Compare |
v5 | 2023-10-02 | French | Compare |
v4 | 2023-10-02 | English | Compare |
v3 | 2023-06-11 | English | Compare |
v2 | 2023-02-06 | French | Compare |
v1 | 2023-02-06 | English | Compare |
Showing 1 to 8 of 8